BT CEO snaps up 400,000 sharesGSK CEO offloads £2.3 million sharesPoolbeg Pharma chairman ups his stakeAllison Kirkby CEO of BT (BT.A) has bought 400,000 shares at 107p for a total value of £428,000 on 20 February.The move comes as the telecoms giant announced that it was offloading its iconic ?BT Tower? in London?s Fitzrovia to MCR for £275 million.The company announced Kirkby?s appointment la

Stocks in Europe raced higher on Tuesday morning, building on the strong Wall Street session on Monday, with the rally in London boosted by the UK government back-tracking on its unpopular tax-cutting plans.The FTSE 100 index opened up 73.28 points, 1.1%, at 6,982.04. The FTSE 250 opened up 274.82 points, 1.6%, at 17,558.98 and the AIM All-Share opened up 6.51 points, 0.8% at 815.24.The Cboe UK 10

THIS IS AN ADVERTISING PROMOTIONInfectious diseases have, over the last decade, been a relatively under-funded area of pharmaceutical research with 'Big Pharma' deprioritising R&D in this space.But then an unprecedented global pandemic brought about devastating human and economic damage, the impact of which will take a generation to overcome. For the pharmaceutical and biotech sectors, it has brou

It all started in September 2007 and for many it would be the beginning of the end for banking as they knew it. When retail lender Northern Rock approached the Bank of England for emergency funding five years ago it became the start of one of the worst periods in the banking sector's history.Northern Rock's model of lending long-term mortgages while borrowing short-term through securitising its lo